3BP-227 / FPI-2059
Pancreatic adenocarcinoma & other NTR1+ tumors
UnknownActive
Key Facts
Indication
Pancreatic adenocarcinoma & other NTR1+ tumors
Phase
Unknown
Status
Active
Company
About 3B Pharmaceuticals
3B Pharmaceuticals is a German biotech specializing in targeted radiopharmaceuticals for cancer diagnosis and therapy. The company has built a diversified pipeline targeting pan-tumor antigens like FAP, as well as NTR1, CAIX, and GIP receptors, with key assets partnered with major players like Novartis and Debiopharm. Operating as a private, R&D-focused entity, 3B leverages its proprietary platform to develop novel radioligands, positioning itself in the rapidly growing field of precision oncology and theranostics.
View full company profile